Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1992 1
1996 2
1997 1
2000 2
2001 2
2002 3
2003 3
2004 5
2005 3
2006 2
2007 9
2008 2
2009 1
2010 2
2011 4
2012 5
2013 4
2014 9
2015 11
2016 15
2017 15
2018 7
2019 3
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Schuster SJ, Bishop MR, Tam CS, Waller EK, Borchmann P, McGuirk JP, Jäger U, Jaglowski S, Andreadis C, Westin JR, Fleury I, Bachanova V, Foley SR, Ho PJ, Mielke S, Magenau JM, Holte H, Pantano S, Pacaud LB, Awasthi R, Chu J, Anak Ö, Salles G, Maziarz RT; JULIET Investigators. Schuster SJ, et al. N Engl J Med. 2019 Jan 3;380(1):45-56. doi: 10.1056/NEJMoa1804980. Epub 2018 Dec 1. N Engl J Med. 2019. PMID: 30501490 Clinical Trial.
Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma.
Kumar S, Flinn I, Richardson PG, Hari P, Callander N, Noga SJ, Stewart AK, Turturro F, Rifkin R, Wolf J, Estevam J, Mulligan G, Shi H, Webb IJ, Rajkumar SV. Kumar S, et al. Among authors: turturro f. Blood. 2012 May 10;119(19):4375-82. doi: 10.1182/blood-2011-11-395749. Epub 2012 Mar 15. Blood. 2012. PMID: 22422823 Free article. Clinical Trial.
A clinician's guide to double hit lymphomas.
Cheah CY, Oki Y, Westin JR, Turturro F. Cheah CY, et al. Among authors: turturro f. Br J Haematol. 2015 Mar;168(6):784-95. doi: 10.1111/bjh.13276. Epub 2014 Dec 22. Br J Haematol. 2015. PMID: 25529575 Free article. Review.
A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL.
Cherng HJ, Alig SK, Oki Y, Nastoupil LJ, Fayad L, Neelapu SS, Turturro F, Hagemeister F, Craig AFM, Macaulay CW, Rodriguez MA, Lee HJ, McDonnell TJ, Flowers CR, Vega F, Green MR, Feng L, Kurtz DM, Alizadeh AA, Davis RE, Westin JR. Cherng HJ, et al. Among authors: turturro f. Blood Adv. 2023 Apr 11;7(7):1137-1145. doi: 10.1182/bloodadvances.2022008174. Blood Adv. 2023. PMID: 36375046 Free PMC article. Clinical Trial.
Oligosecretory biclonal multiple myeloma.
Koshy N, Ong MG, Nordberg ML, Turturro F, Cotelingam JD. Koshy N, et al. Among authors: turturro f. J La State Med Soc. 2013 Jul-Aug;165(4):215, 217-8. J La State Med Soc. 2013. PMID: 24133785
Thioredoxin-interacting protein and chronic lymphocytic leukemia.
Friday E, Koshy N, Bhanderi V, Turturro F. Friday E, et al. Among authors: turturro f. Leuk Lymphoma. 2012 Mar;53(3):492-4. doi: 10.3109/10428194.2011.607730. Epub 2011 Nov 15. Leuk Lymphoma. 2012. PMID: 21916829 No abstract available.
95 results